Workflow
东北证券:予威高股份“买入”评级 通过MDSAP认证助力产品加速出海
Zhi Tong Cai Jing·2025-09-22 06:17

Core Viewpoint - Northeast Securities has given a "buy" rating to Weigao Group (01066) following its successful acquisition of MDSAP certification, which will facilitate the international expansion of its products [1] Group 1: Company Performance and Projections - The company is a leading provider of comprehensive medical system solutions in China, focusing on platformization, internationalization, and digitalization to maintain its market leadership [1] - Revenue projections for Weigao Group are estimated at 135.41 billion, 149.60 billion, and 163.01 billion yuan for the years 2025 to 2027, with net profits of 20.76 billion, 23.57 billion, and 26.05 billion yuan respectively, corresponding to PE ratios of 12X, 10X, and 9X [1] Group 2: MDSAP Certification and Product Development - The MDSAP certification is recognized by regulatory bodies in the US, Australia, Brazil, Canada, and Japan, allowing manufacturers to streamline their quality management system audits, thus saving time and resources [2] - The company plans to enhance its product matrix by transitioning from low-cost to high-cost/specialized products, with over 100 new products expected to be approved in the next three years [2] - The orthopedic segment will focus on new materials, regenerative rehabilitation, smart assistance, and 3D printing, particularly in minimally invasive spine and pain management [2] - The company is also expanding its blood management segment, with a projected production capacity of over 100 million blood bags by 2025 and an additional 20 million overseas capacity expected next year [2] Group 3: International Revenue and Acquisitions - In the first half of 2025, the company achieved overseas revenue of 16.24 billion yuan, a year-on-year increase of 3.98%, accounting for 24.44% of total revenue, with significant growth in the US and EMEA regions [3] - Recent acquisitions include Argon, a US interventional device manufacturer, GHC Healthcare, a medical device distributor, and Radsource, a blood irradiation device manufacturer, which have been integrated to enhance synergies [3]